Activin Receptor-Like Kinase and the Insulin Gene

Vitamins and Hormones

Volumn 85, Issue , 2011, Pages 1-27

  Watanabe, Rie ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Activin A; Activin AB; Activin B; ALK4; ALK7; Nodal; Smad binding element (SBE); The insulin gene

Indexed keywords

ACTIVIN RECEPTOR; INSULIN; ISOENZYME;

ANIMAL; BOOK; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PANCREAS; PHYSIOLOGY;

ACTIVIN RECEPTORS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INSULIN; ISOENZYMES; PANCREAS;

EID: 79951899292     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385961-7.00001-9     Document Type: Book

References (199)

1. Adkins H.B., Bianco C., Schiffer S.G., Rayhorn P., Zafari M., Cheung A.E., Orozco O., Olson D., De Luca A., Chen L.L., Miatkowski K., Benjamin C., et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J. Clin. Invest. 2003, 112:575-587.
2. Andersson O., Reissmann E., Ibanez C.F. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep. 2006, 7:831-837.
3. Andersson O., Reissmann E., Jornvall H., Ibanez C.F. Synergistic interaction between Gdf1 and Nodal during anterior axis development. Dev. Biol. 2006, 293:370-381.
4. Andersson O., Korach-Andre M., Reissmann E., Ibanez C.F., Bertolino P. Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc. Natl. Acad. Sci. USA 2008, 105:7252-7256.
5. Attisano L., Wrana J.L., Cheifetz S., Massague J. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 1992, 68:97-108.
6. Attisano L., Carcamo J., Ventura F., Weis F.M., Massague J., Wrana J.L. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993, 75:671-680.
7. Ban N., Yamada Y., Someya Y., Ihara Y., Adachi T., Kubota A., Watanabe R., Kuroe A., Inada A., Miyawaki K., Sunaga Y., Shen Z.P., et al. Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes 2000, 49:1142-1148.
8. Bell G.I., Pictet R.L., Rutter W.J., Cordell B., Tischer E., Goodman H.M. Sequence of the human insulin gene. Nature 1980, 284:26-32.
9. Benkhelifa S., Provot S., Lecoq O., Pouponnot C., Calothy G., Felder-Schmittbuhl M.P. mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells. Oncogene 1998, 17:247-254.
10. Bertolino P., Holmberg R., Reissmann E., Andersson O., Berggren P.O., Ibanez C.F. Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc. Natl. Acad. Sci. USA 2008, 105:7246-7251.
11. Boam D.S., Docherty K. A tissue-specific nuclear factor binds to multiple sites in the human insulin-gene enhancer. Biochem. J. 1989, 264:233-239.
12. Boam D.S., Clark A.R., Docherty K. Positive and negative regulation of the human insulin gene by multiple trans-acting factors. J. Biol. Chem. 1990, 265:8285-8296.
13. Bondestam J., Huotari M.A., Moren A., Ustinov J., Kaivo-Oja N., Kallio J., Horelli-Kuitunen N., Aaltonen J., Fujii M., Moustakas A., Ten Dijke P., Otonkoski T., et al. cDNA cloning, expression studies and chromosome mapping of human type I serine/threonine kinase receptor ALK7 (ACVR1C). Cytogenet. Cell Genet. 2001, 95:157-162.
14. Brown C.W., Houston-Hawkins D.E., Woodruff T.K., Matzuk M.M. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat. Genet. 2000, 25:453-457.
15. Cakir Y., Ballinger S.W. Reactive species-mediated regulation of cell signaling and the cell cycle: The role of MAPK. Antioxid. Redox Signal. 2005, 7:726-740.
16. Campbell S.C., Cragg H., Elrick L.J., Macfarlane W.M., Shennan K.I., Docherty K. Inhibitory effect of pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters. FEBS Lett. 1999, 463:53-57.
17. Cheifetz S., Like B., Massague J. Cellular distribution of type I and type II receptors for transforming growth factor-beta. J. Biol. Chem. 1986, 261:9972-9978.
18. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., Letarte M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 1992, 267:19027-19030.
19. Cissell M.A., Zhao L., Sussel L., Henderson E., Stein R. Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2. J. Biol. Chem. 2003, 278:751-756.
20. Crowe D.T., Tsai M.J. Mutagenesis of the rat insulin II 5'-flanking region defines sequences important for expression in HIT cells. Mol. Cell. Biol. 1989, 9:1784-1789.
21. Cunha D.A., Carneiro E.M., Alves Mde C., Jorge A.G., de Sousa S.M., Boschero A.C., Saad M.J., Velloso L.A., Rocha E.M. Insulin secretion by rat lacrimal glands: Effects of systemic and local variables. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E768-E775.
22. Daly A.C., Randall R.A., Hill C.S. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 2008, 28:6889-6902.
23. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 2005, 23:1534-1541.
24. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., Moorman M.A., Kroon E., Carpenter M.K., Baetge E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
25. da Silva Xavier G., Rutter J., Rutter G.A. Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose. Proc. Natl. Acad. Sci. USA 2004, 101:8319-8324.
26. Devaskar S.U., Giddings S.J., Rajakumar P.A., Carnaghi L.R., Menon R.K., Zahm D.S. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 1994, 269:8445-8454.
27. Docherty H.M., Hay C.W., Ferguson L.A., Barrow J., Durward E., Docherty K. Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter. Biochem. J. 2005, 389:813-820.
28. Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 1987, 84:3434-3438.
29. Dumonteil E., Laser B., Constant I., Philippe J. Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2. J. Biol. Chem. 1998, 273:19945-19954.
30. Ebner R., Chen R.H., Shum L., Lawler S., Zioncheck T.F., Lee A., Lopez A.R., Derynck R. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science 1993, 260:1344-1348.
31. Edlund T., Walker M.D., Barr P.J., Rutter W.J. Cell-specific expression of the rat insulin gene: Evidence for role of two distinct 5' flanking elements. Science 1985, 230:912-916.
32. Fang J., Yin W., Smiley E., Wang S.Q., Bonadio J. Molecular cloning of the mouse activin beta E subunit gene. Biochem. Biophys. Res. Commun. 1996, 228:669-674.
33. Fang J., Wang S.Q., Smiley E., Bonadio J. Genes coding for mouse activin beta C and beta E are closely linked and exhibit a liver-specific expression pattern in adult tissues. Biochem. Biophys. Res. Commun. 1997, 231:655-661.
34. Finnson K.W., Parker W.L., ten Dijke P., Thorikay M., Philip A. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J. Bone Miner. Res. 2008, 23:896-906.
35. Florio P., Luisi S., Marchetti P., Lupi R., Cobellis L., Falaschi C., Sugino H., Navalesi R., Genazzani A.R., Petraglia F. Activin A stimulates insulin secretion in cultured human pancreatic islets. J. Endocrinol. Invest. 2000, 23:231-234.
36. Frandsen U., Porneki A.D., Floridon C., Abdallah B.M., Kassem M. Activin B mediated induction of Pdx1 in human embryonic stem cell derived embryoid bodies. Biochem. Biophys. Res. Commun. 2007, 362:568-574.
37. Franzén P., ten Dijke P., Ichijo H., Yamashita H., Schulz P., Heldin C.H., Miyazono K. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 1993, 75:681-692.
38. Fujitani Y., Kajimoto Y., Yasuda T., Matsuoka T.A., Kaneto H., Umayahara Y., Fujita N., Watada H., Miyazaki J.I., Yamasaki Y., Hori M. Identification of a portable repression domain and an E1A-responsive activation domain in Pax4: A possible role of Pax4 as a transcriptional repressor in the pancreas. Mol. Cell. Biol. 1999, 19:8281-8291.
39. Furukawa M., Eto Y., Kojima I. Expression of immunoreactive activin A in fetal rat pancreas. Endocr. J. 1995, 42:63-68.
40. Gamer L.W., Wright C.V. Autonomous endodermal determination in Xenopus: Regulation of expression of the pancreatic gene XlHbox 8. Dev. Biol. 1995, 171:240-251.
41. Georgi L.L., Albert P.S., Riddle D.L. daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 1990, 61:635-645.
42. German M.S., Wang J., Chadwick R.B., Rutter W.J. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: Building a functional insulin minienhancer complex. Genes Dev. 1992, 6:2165-2176.
43. German M., Ashcroft S., Docherty K., Edlund H., Edlund T., Goodison S., Imura H., Kennedy G., Madsen O., Melloul D., et al. The insulin gene promoter. A simplified nomenclature. Diabetes 1995, 44:1002-1004.
44. Glick E., Leshkowitz D., Walker M.D. Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J. Biol. Chem. 2000, 275:2199-2204.
45. Gougos A., Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 1990, 265:8361-8364.
46. Goulley J., Dahl U., Baeza N., Mishina Y., Edlund H. BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion. Cell Metab. 2007, 5:207-219.
47. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., Karlsson S., ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell 2003, 12:817-828.
48. Gray P.C., Harrison C.A., Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. USA 2003, 100:5193-5198.
49. Grill V., Cerasi E. Stimulation by D-glucose of cyclic adenosine 3':5'-monophosphate accumulation and insulin release in isolated pancreatic islets of the rat. J. Biol. Chem. 1974, 249:4196-4201.
50. Groppe J., Hinck C.S., Samavarchi-Tehrani P., Zubieta C., Schuermann J.P., Taylor A.B., Schwarz P.M., Wrana J.L., Hinck A.P. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 2008, 29:157-168.
51. Harper M.E., Ullrich A., Saunders G.F. Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc. Natl. Acad. Sci. USA 1981, 78:4458-4460.
52. Harrison C.A., Gray P.C., Koerber S.C., Fischer W., Vale W. Identification of a functional binding site for activin on the type I receptor ALK4. J. Biol. Chem. 2003, 278:21129-21135.
53. Hart P.J., Deep S., Taylor A.B., Shu Z., Hinck C.S., Hinck A.P. Crystal structure of the human TbetaR2 ectodomain-TGF-beta3 complex. Nat. Struct. Biol. 2002, 9:203-208.
54. Hashimoto O., Tsuchida K., Ushiro Y., Hosoi Y., Hoshi N., Sugino H., Hasegawa Y. cDNA cloning and expression of human activin betaE subunit. Mol. Cell. Endocrinol. 2002, 194:117-122.
55. Hay C.W., Docherty K. Comparative analysis of insulin gene promoters: Implications for diabetes research. Diabetes 2006, 55:3201-3213.
56. Hay C.W., Sinclair E.M., Bermano G., Durward E., Tadayyon M., Docherty K. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site. J. Endocrinol. 2005, 186:353-365.
57. Hay C.W., Ferguson L.A., Docherty K. ATF-2 stimulates the human insulin promoter through the conserved CRE2 sequence. Biochim. Biophys. Acta 2007, 1769:79-91.
58. He W.W., Gustafson M.L., Hirobe S., Donahoe P.K. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev. Dyn. 1993, 196:133-142.
59. Hebrok M., Kim S.K., Melton D.A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 1998, 12:1705-1713.
60. Henry G.L., Brivanlou I.H., Kessler D.S., Hemmati-Brivanlou A., Melton D.A. TGF-beta signals and a pattern in Xenopus laevis endodermal development. Development 1996, 122:1007-1015.
61. Hino M., Tojo A., Miyazono K., Miura Y., Chiba S., Eto Y., Shibai H., Takaku F. Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells. J. Biol. Chem. 1989, 264:10309-10314.
62. Hötten G., Neidhardt H., Schneider C., Pohl J. Cloning of a new member of the TGF-beta family: A putative new activin beta C chain. Biochem. Biophys. Res. Commun. 1995, 206:608-613.
63. Inagaki N., Maekawa T., Sudo T., Ishii S., Seino Y., Imura H. c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Proc. Natl. Acad. Sci. USA 1992, 89:1045-1049.
64. Jiang W., Shi Y., Zhao D., Chen S., Yong J., Zhang J., Qing T., Sun X., Zhang P., Ding M., Li D., Deng H. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007, 17:333-344.
65. Jolicoeur C., Hanahan D., Smith K.M. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl. Acad. Sci. USA 1994, 91:6707-6711.
66. Kajihara M., Sone H., Amemiya M., Katoh Y., Isogai M., Shimano H., Yamada N., Takahashi S. Mouse MafA, homologue of zebrafish somite Maf 1, contributes to the specific transcriptional activity through the insulin promoter. Biochem. Biophys. Res. Commun. 2003, 312:831-842.
67. Kang Y., Reddi A.H. Identification and cloning of a novel type I serine/threonine kinase receptor of the TGF-beta/BMP superfamily in rat prostate. Biochem. Mol. Biol. Int. 1996, 40:993-1001.
68. Karlsson O., Edlund T., Moss J.B., Rutter W.J., Walker M.D. A mutational analysis of the insulin gene transcription control region: Expression in beta cells is dependent on two related sequences within the enhancer. Proc. Natl. Acad. Sci. USA 1987, 84:8819-8823.
69. Karlsson O., Walker M.D., Rutter W.J., Edlund T. Individual protein-binding domains of the insulin gene enhancer positively activate beta-cell-specific transcription. Mol. Cell. Biol. 1989, 9:823-827.
70. Kataoka K., Han S.I., Shioda S., Hirai M., Nishizawa M., Handa H. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J. Biol. Chem. 2002, 277:49903-49910.
71. Kawabata M., Chytil A., Moses H.L. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. J. Biol. Chem. 1995, 270:5625-5630.
72. Kelber J.A., Shani G., Booker E.C., Vale W.W., Gray P.C. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J. Biol. Chem. 2008, 283:4490-4500.
73. Kerppola T.K., Curran T. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene 1994, 9:3149-3158.
74. Kim S.K., Hebrok M., Li E., Oh S.P., Schrewe H., Harmon E.B., Lee J.S., Melton D.A. Activin receptor patterning of foregut organogenesis. Genes Dev. 2000, 14:1866-1871.
75. Kojima H., Fujimiya M., Matsumura K., Nakahara T., Hara M., Chan L. Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc. Natl. Acad. Sci. USA 2004, 101:2458-2463.
76. Ku H.T., Zhang N., Kubo A., O'Connor R., Mao M., Keller G., Bromberg J.S. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 2004, 22:1205-1217.
77. Kubo A., Shinozaki K., Shannon J.M., Kouskoff V., Kennedy M., Woo S., Fehling H.J., Keller G. Development of definitive endoderm from embryonic stem cells in culture. Development 2004, 131:1651-1662.
78. Kuroda A., Rauch T.A., Todorov I., Ku H.T., Al-Abdullah I.H., Kandeel F., Mullen Y., Pfeifer G.P., Ferreri K. Insulin gene expression is regulated by DNA methylation. PLoS ONE 2009, 4:e6953.
79. La Rosa S., Uccella S., Marchet S., Capella C., Lloyd R.V. Localization of Inhibins and Activins in normal endocrine cells and endocrine tumors of the gut and pancreas: An immunohistochemical and in situ hybridization study. J. Histochem. Cytochem. 2004, 52:217-225.
80. Lau A.L., Nishimori K., Matzuk M.M. Structural analysis of the mouse activin beta C gene. Biochim. Biophys. Acta 1996, 1307:145-148.
81. Lee S.J., Reed L.A., Davies M.V., Girgenrath S., Goad M.E., Tomkinson K.N., Wright J.F., Barker C., Ehrmantraut G., Holmstrom J., Trowell B., Gertz B., et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl. Acad. Sci. USA 2005, 102:18117-18122.
82. Legerski R., Zhou X., Dresback J., Eberspaecher H., McKinney S., Segarini P., de Crombrugghe B. Molecular cloning and characterization of a novel rat activin receptor. Biochem. Biophys. Res. Commun. 1992, 183:672-679.
83. Le Lay J., Stein R. Involvement of PDX-1 in activation of human insulin gene transcription. J. Endocrinol. 2006, 188:287-294.
84. Le Lay J., Matsuoka T.A., Henderson E., Stein R. Identification of a novel PDX-1 binding site in the human insulin gene enhancer. J. Biol. Chem. 2004, 279:22228-22235.
85. Leonard J., Peers B., Johnson T., Ferreri K., Lee S., Montminy M.R. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol. Endocrinol. 1993, 7:1275-1283.
86. Liberzon A., Ridner G., Walker M.D. Role of intrinsic DNA binding specificity in defining target genes of the mammalian transcription factor PDX1. Nucleic Acids Res. 2004, 32:54-64.
87. Lin H.Y., Wang X.F., Ng-Eaton E., Weinberg R.A., Lodish H.F. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992, 68:775-785.
88. Lin S.J., Lerch T.F., Cook R.W., Jardetzky T.S., Woodruff T.K. The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction 2006, 132:179-190.
89. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., Hotta M., Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of Inhibin. Nature 1986, 321:779-782.
90. Liu F., Ventura F., Doody J., Massague J. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 1995, 15:3479-3486.
91. Liu I.M., Schilling S.H., Knouse K.A., Choy L., Derynck R., Wang X.F. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J. 2009, 28:88-98.
92. Lönn P., Morén A., Raja E., Dahl M., Moustakas A. Regulating the stability of TGFbeta receptors and Smads. Cell Res. 2009, 19:21-35.
93. López-Casillas F., Cheifetz S., Doody J., Andres J.L., Lane W.S., Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 1991, 67:785-795.
94. Lorentzon M., Hoffer B., Ebendal T., Olson L., Tomac A. Habrec1, a novel serine/threonine kinase TGF-beta type I-like receptor, has a specific cellular expression suggesting function in the developing organism and adult brain. Exp. Neurol. 1996, 142:351-360.
95. MacFarlane W.M., Read M.L., Gilligan M., Bujalska I., Docherty K. Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner. Biochem. J. 1994, 303(Pt 2):625-631.
96. Macgregor P.F., Abate C., Curran T. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1. Oncogene 1990, 5:451-458.
97. Marshak S., Totary H., Cerasi E., Melloul D. Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc. Natl. Acad. Sci. USA 1996, 93:15057-15062.
98. Mashima H., Ohnishi H., Wakabayashi K., Mine T., Miyagawa J., Hanafusa T., Seno M., Yamada H., Kojima I. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 1996, 97:1647-1654.
99. Mashima H., Shibata H., Mine T., Kojima I. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology 1996, 137:3969-3976.
100. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
101. Massague J., Like B. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem. 1985, 260:2636-2645.
102. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
103. Mathews L.S., Vale W.W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991, 65:973-982.
104. Mathews L.S., Vale W.W., Kintner C.R. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 1992, 255:1702-1705.
105. Matsuoka T.A., Zhao L., Artner I., Jarrett H.W., Friedman D., Means A., Stein R. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell. Biol. 2003, 23:6049-6062.
106. Matsuzaki K., Xu J., Wang F., McKeehan W.L., Krummen L., Kan M. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. J. Biol. Chem. 1993, 268:12719-12723.
107. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., Bradley A. Functional analysis of activins during mammalian development. Nature 1995, 374:354-356.
108. McDowell N., Gurdon J.B. Activin as a morphogen in Xenopus mesoderm induction. Semin. Cell Dev. Biol. 1999, 10:311-317.
109. Melloul D., Ben-Neriah Y., Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc. Natl. Acad. Sci. USA 1993, 90:3865-3869.
110. Melloul D., Marshak S., Cerasi E. Regulation of insulin gene transcription. Diabetologia 2002, 45:309-326.
111. Miller C.P., McGehee R.E., Habener J.F. IDX-1: A new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J. 1994, 13:1145-1156.
112. Miralles F., Czernichow P., Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 1998, 125:1017-1024.
113. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 2010, 147:35-51.
114. Mogami H., Kanzaki M., Nobusawa R., Zhang Y.Q., Furukawa M., Kojima I. Modulation of adenosine triphosphate-sensitive potassium channel and voltage-dependent calcium channel by activin A in HIT-T15 cells. Endocrinology 1995, 136:2960-2966.
115. Moriya N., Komazaki S., Takahashi S., Yokota C., Asashima M. In vitro pancreas formation from Xenopus ectoderm treated with activin and retinoic acid. Dev. Growth Differ. 2000, 42:593-602.
116. Moss L.G., Moss J.B., Rutter W.J. Systematic binding analysis of the insulin gene transcription control region: Insulin and immunoglobulin enhancers utilize similar transactivators. Mol. Cell. Biol. 1988, 8:2620-2627.
117. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
118. Mukherjee A., Sidis Y., Mahan A., Raher M.J., Xia Y., Rosen E.D., Bloch K.D., Thomas M.K., Schneyer A.L. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. USA 2007, 104:1348-1353.
119. Nakamura T., Asashima M., Eto Y., Takio K., Uchiyama H., Moriya N., Ariizumi T., Yashiro T., Sugino K., Titani K., et al. Isolation and characterization of native activin B. J. Biol. Chem. 1992, 267:16385-16389.
120. Naya F.J., Stellrecht C.M., Tsai M.J. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 1995, 9:1009-1019.
121. Nelson C., Shen L.P., Meister A., Fodor E., Rutter W.J. Pan: A transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev. 1990, 4:1035-1043.
122. Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wolsing D.H., Rosenbaum J.S. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem. 1995, 270:22522-22526.
123. O'Bryan M.K., Sebire K.L., Gerdprasert O., Hedger M.P., Hearn M.T., de Kretser D.M. Cloning and regulation of the rat activin betaE subunit. J. Mol. Endocrinol. 2000, 24:409-418.
124. Odagiri H., Wang J., German M.S. Function of the human insulin promoter in primary cultured islet cells. J. Biol. Chem. 1996, 271:1909-1915.
125. Oetjen E., Diedrich T., Eggers A., Eckert B., Knepel W. Distinct properties of the cAMP-responsive element of the rat insulin I gene. J. Biol. Chem. 1994, 269:27036-27044.
126. Offield M.F., Jetton T.L., Labosky P.A., Ray M., Stein R.W., Magnuson M.A., Hogan B.L., Wright C.V. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996, 122:983-995.
127. Ogawa K., Abe K., Kurosawa N., Kurohmaru M., Sugino H., Takahashi M., Hayashi Y. Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett. 1993, 319:217-220.
128. Ogawa K., Ono K., Kurohmaru M., Hayashi Y. Effect of streptozotocin injection on expression of immunoreactive follistatin and beta A and beta B subunits of inhibin/activin in rat pancreatic islets. Eur. J. Endocrinol. 1995, 132:363-369.
129. Ohlsson H., Edlund T. Sequence-specific interactions of nuclear factors with the insulin gene enhancer. Cell 1986, 45:35-44.
130. Ohlsson H., Karlsson O., Edlund T. A beta-cell-specific protein binds to the two major regulatory sequences of the insulin gene enhancer. Proc. Natl. Acad. Sci. USA 1988, 85:4228-4231.
131. Ohlsson H., Karlsson K., Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 1993, 12:4251-4259.
132. Ohneda K., Mirmira R.G., Wang J., Johnson J.D., German M.S. The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol. Cell Biol. 2000, 20:900-911.
133. Okita K., Yang Q., Yamagata K., Hangenfeldt K.A., Miyagawa J., Kajimoto Y., Nakajima H., Namba M., Wollheim C.B., Hanafusa T., Matsuzawa Y. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta. Biochem. Biophys. Res. Commun. 1999, 263:566-569.
134. Olbrot M., Rud J., Moss L.G., Sharma A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. USA 2002, 99:6737-6742.
135. Owerbach D., Bell G.I., Rutter W.J., Shows T.B. The insulin gene is located on chromosome 11 in humans. Nature 1980, 286:82-84.
136. Paralkar V.M., Hammonds R.G., Reddi A.H. Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. Proc. Natl. Acad. Sci. USA 1991, 88:3397-3401.
137. Petersen H.V., Serup P., Leonard J., Michelsen B.K., Madsen O.D. Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. Proc. Natl. Acad. Sci. USA 1994, 91:10465-10469.
138. Peyton M., Moss L.G., Tsai M.J. Two distinct class A helix-loop-helix transcription factors, E2A and BETA1, form separate DNA binding complexes on the insulin gene E box. J. Biol. Chem. 1994, 269:25936-25941.
139. Pugliese A. Insulin expression in the thymus, tolerance, and type 1 diabetes. Diabetes Metab. Rev. 1998, 14:325-327.
140. Pugliese A., Zeller M., Fernandez A., Zalcberg L.J., Bartlett R.J., Ricordi C., Pietropaolo M., Eisenbarth G.S., Bennett S.T., Patel D.D. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 1997, 15:293-297.
141. Qiu Y., Guo M., Huang S., Stein R. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol. Cell. Biol. 2002, 22:412-420.
142. Read M.L., Clark A.R., Docherty K. The helix-loop-helix transcription factor USF (upstream stimulating factor) binds to a regulatory sequence of the human insulin gene enhancer. Biochem. J. 1993, 295(Pt 1):233-237.
143. Read M.L., Masson M.R., Docherty K. A RIPE3b1-like factor binds to a novel site in the human insulin promoter in a redox-dependent manner. FEBS Lett. 1997, 418:68-72.
144. Rebbapragada A., Benchabane H., Wrana J.L., Celeste A.J., Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 2003, 23:7230-7242.
145. Reissmann E., Jornvall H., Blokzijl A., Andersson O., Chang C., Minchiotti G., Persico M.G., Ibanez C.F., Brivanlou A.H. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev. 2001, 15:2010-2022.
146. Ricordi C., Edlund H. Toward a renewable source of pancreatic beta-cells. Nat. Biotechnol. 2008, 26:397-398.
147. Rosenzweig J.L., Havrankova J., Lesniak M.A., Brownstein M., Roth J. Insulin is ubiquitous in extrapancreatic tissues of rats and humans. Proc. Natl. Acad. Sci. USA 1980, 77:572-576.
148. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C.H., Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA 1995, 92:7632-7636.
149. Rudnick A., Ling T.Y., Odagiri H., Rutter W.J., German M.S. Pancreatic beta cells express a diverse set of homeobox genes. Proc. Natl. Acad. Sci. USA 1994, 91:12203-12207.
150. Rydén M., Imamura T., Jornvall H., Belluardo N., Neveu I., Trupp M., Okadome T., ten Dijke P., Ibanez C.F. A novel type I receptor serine-threonine kinase predominantly expressed in the adult central nervous system. J. Biol. Chem. 1996, 271:30603-30609.
151. Sander M., Neubuser A., Kalamaras J., Ee H.C., Martin G.R., German M.S. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 1997, 11:1662-1673.
152. Sanvito F., Herrera P.L., Huarte J., Nichols A., Montesano R., Orci L., Vassalli J.D. TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development 1994, 120:3451-3462.
153. Schier A.F., Shen M.M. Nodal signalling in vertebrate development. Nature 2000, 403:385-389.
154. Schmierer B., Hill C.S. TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 2007, 8:970-982.
155. Schmitt J., Hotten G., Jenkins N.A., Gilbert D.J., Copeland N.G., Pohl J., Schrewe H. Structure, chromosomal localization, and expression analysis of the mouse inhibin/activin beta C (Inhbc) gene. Genomics 1996, 32:358-366.
156. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996, 10:709-720.
157. Sharma A., Stein R. Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-type-specific expression. Mol. Cell. Biol. 1994, 14:871-879.
158. Sharma A., Fusco-DeMane D., Henderson E., Efrat S., Stein R. The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene. Mol. Endocrinol. 1995, 9:1468-1476.
159. Shen M.M. Nodal signaling: developmental roles and regulation. Development 2007, 134:1023-1034.
160. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
161. Shi Y., Hou L., Tang F., Jiang W., Wang P., Ding M., Deng H. Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 2005, 23:656-662.
162. Shibata H., Yasuda H., Sekine N., Mine T., Totsuka Y., Kojima I. Activin A increases intracellular free calcium concentrations in rat pancreatic islets. FEBS Lett. 1993, 329:194-198.
163. Shibata H., Kanzaki M., Takeuchi T., Miyazaki J., Kojima I. Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines. J. Mol. Endocrinol. 1996, 16:249-258.
164. Shieh S.Y., Tsai M.J. Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. J. Biol. Chem. 1991, 266:16708-16714.
165. Shiozaki S., Tajima T., Zhang Y.Q., Furukawa M., Nakazato Y., Kojima I. Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor. Biochim. Biophys. Acta 1999, 1450:1-11.
166. Smart N.G., Apelqvist A.A., Gu X., Harmon E.B., Topper J.N., MacDonald R.J., Kim S.K. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol. 2006, 4:e39.
167. Smith K.M., Olson D.C., Hirose R., Hanahan D. Pancreatic gene expression in rare cells of thymic medulla: Evidence for functional contribution to T cell tolerance. Int. Immunol. 1997, 9:1355-1365.
168. Soares M.B., Schon E., Henderson A., Karathanasis S.K., Cate R., Zeitlin S., Chirgwin J., Efstratiadis A. RNA-mediated gene duplication: The rat preproinsulin I gene is a functional retroposon. Mol. Cell. Biol. 1985, 5:2090-2103.
169. Steiner D.F., Chan S.J., Welsh J.M., Kwok S.C. Structure and evolution of the insulin gene. Annu. Rev. Genet. 1985, 19:463-484.
170. ten Dijke P., Ichijo H., Franzén P., Schulz P., Saras J., Toyoshima H., Heldin C.H., Miyazono K. Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 1993, 8:2879-2887.
171. ten Dijke P., Yamashita H., Ichijo H., Franzén P., Laiho M., Miyazono K., Heldin C.H. Characterization of type I receptors for transforming growth factor-beta and activin. Science 1994, 264:101-104.
172. Tomonari A., Yoshimoto K., Mizusawa N., Iwahana H., Itakura M. Differential regulation of the human insulin gene transcription by GG1 and GG2 elements with GG- and C1-binding factors. Biochim. Biophys. Acta 1999, 1446:233-242.
173. Totsuka Y., Tabuchi M., Kojima I., Shibai H., Ogata E. A novel action of activin A: Stimulation of insulin secretion in rat pancreatic islets. Biochem. Biophys. Res. Commun. 1988, 156:335-339.
174. Tsuchida K., Sawchenko P.E., Nishikawa S., Vale W.W. Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain. Mol. Cell. Neurosci. 1996, 7:467-478.
175. Tsuchida K., Nakatani M., Yamakawa N., Hashimoto O., Hasegawa Y., Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol. Cell. Endocrinol. 2004, 220:59-65.
176. Tsuchida K., Nakatani M., Hitachi K., Uezumi A., Sunada Y., Ageta H., Inokuchi K. Activin signaling as an emerging target for therapeutic interventions. Cell Commun Signal 2009, 7:15.
177. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., Wickramasinghe S., Colle E., Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 1997, 15:289-292.
178. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., Karr D., Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986, 321:776-779.
179. Vallejo G., Mead P.M., Gaynor D.H., Devlin J.T., Robbins D.C. Characterization of immunoreactive insulin in human saliva: Evidence against production in situ. Diabetologia 1984, 27:437-440.
180. Vassalli A., Matzuk M.M., Gardner H.A., Lee K.F., Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 1994, 8:414-427.
181. Vejda S., Cranfield M., Peter B., Mellor S.L., Groome N., Schulte-Hermann R., Rossmanith W. Expression and dimerization of the rat activin subunits betaC and betaE: Evidence for the ormation of novel activin dimers. J. Mol. Endocrinol. 2002, 28:137-148.
182. Verspohl E.J., Ammon H.P., Wahl M.A. Activin A: Its effects on rat pancreatic islets and the mechanism of action involved. Life Sci. 1993, 53:1069-1078.
183. Wada M., Shintani Y., Kosaka M., Sano T., Hizawa K., Saito S. Immunohistochemical localization of activin A and follistatin in human tissues. Endocr. J. 1996, 43:375-385.
184. Walker M.D., Edlund T., Boulet A.M., Rutter W.J. Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes. Nature 1983, 306:557-561.
185. Walker M.D., Park C.W., Rosen A., Aronheim A. A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res. 1990, 18:1159-1166.
186. Wang X.F., Lin H.Y., Ng-Eaton E., Downward J., Lodish H.F., Weinberg R.A. Expression cloning and characterization of the TGF-beta type III receptor. Cell 1991, 67:797-805.
187. Watanabe R., Yamada Y., Ihara Y., Someya Y., Kubota A., Kagimoto S., Kuroe A., Iwakura T., Shen Z.P., Inada A., Adachi T., Ban N., et al. The MH1 domains of smad2 and smad3 are involved in the regulation of the ALK7 signals. Biochem. Biophys. Res. Commun. 1999, 254:707-712.
188. Watanabe R., Shen Z.P., Tsuda K., Yamada Y. Insulin gene is a target in activin receptor-like kinase 7 signaling pathway in pancreatic beta-cells. Biochem. Biophys. Res. Commun. 2008, 377:867-872.
189. Whelan J., Poon D., Weil P.A., Stein R. Pancreatic beta-cell-type-specific expression of the rat insulin II gene is controlled by positive and negative cellular transcriptional elements. Mol. Cell. Biol. 1989, 9:3253-3259.
190. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.F., Massague J. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992, 71:1003-1014.
191. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994, 370:341-347.
192. Yamaoka T., Idehara C., Yano M., Matsushita T., Yamada T., Ii S., Moritani M., Hata J., Sugino H., Noji S., Itakura M. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J. Clin. Invest. 1998, 102:294-301.
193. Yasuda H., Inoue K., Shibata H., Takeuchi T., Eto Y., Hasegawa Y., Sekine N., Totsuka Y., Mine T., Ogata E., et al. Existence of activin-A in A- and D-cells of rat pancreatic islet. Endocrinology 1993, 133:624-630.
194. Yasunaga M., Tada S., Torikai-Nishikawa S., Nakano Y., Okada M., Jakt L.M., Nishikawa S., Chiba T., Era T. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat. Biotechnol. 2005, 23:1542-1550.
195. Yeo C., Whitman M. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol. Cell 2001, 7:949-957.
196. Zhang Y.E. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009, 19:128-139.
197. Zhang N., Kumar M., Xu G., Ju W., Yoon T., Xu E., Huang X., Gaisano H., Peng C., Wang Q. Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 2006, 49:506-518.
198. Zhao L., Guo M., Matsuoka T.A., Hagman D.K., Parazzoli S.D., Poitout V., Stein R. The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J. Biol. Chem. 2005, 280:11887-11894.
199. Zuniga J.E., Groppe J.C., Cui Y., Hinck C.S., Contreras-Shannon V., Pakhomova O.N., Yang J., Tang Y., Mendoza V., López-Casillas F., Sun L., Hinck A.P. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. J. Mol. Biol. 2005, 354:1052-1068.